Page 2 - Multiplan Inc News Today

2021 M&A smashed U.S. and global records. The year saw the arrival of a new U.S. administration, the release of COVID-19 vaccines, as well as continued questions regarding the impact of the pandemic...

2021 M&A smashed U.S. and global records. The year saw the arrival of a new U.S. administration, the release of COVID-19 vaccines, as well as continued questions regarding the impact of...

On January 3, 2022, the Delaware Court of Chancery issued a long-awaited and highly-anticipated decision arising out of a challenge to a transaction involving a special purpose...

Delaware Chancery Court issued a decision with major implications for sponsors and directors of Delaware incorporated SPACs. In re MultiPlan Corp. Stockholders Litigation is a suit arising from the purchase of healthcare-data company MultiPlan, Inc.

In an important decision, the Delaware Court of Chancery, in In re Multiplan Corp. Stockholders Litigation, 2022 WL 24060 (Del. Ch. Jan. 3, 2022), in denying the defendants’ motion to...

Second Circuit Affirms Dismissal of Securities Fraud Class Action Against Alkermes; Delaware Court of Chancery Allows SPAC Litigation to Proceed; Ex-Theranos CEO Elizabeth Holmes...

The Delaware Chancery Court has issued a decision with major implications for sponsors and directors of Delaware incorporated special purpose acquisition companies (SPACs).  In re...

Amo v. MultiPlan (Jan. 3, 2022) is the first Delaware decision to address fiduciary duties and related principles in the context of a SPAC (special…

On January 3, 2022, Vice Chancellor Lori W. Will of the Delaware Court of Chancery largely denied a motion to dismiss a putative class action brought by the stockholders of Churchill...

Our Securities Litigation and Securities Groups take a closer look at a technical, fact-specific decision addressing claims brought in connection with a special purpose acquisition...